Vutiglabridin Modulates Paraoxonase 1 and Ameliorates Diet-Induced Obesity in Hyperlipidemic Mice

By sjmartinez • May 16, 2023

Sulaiman D, Choi LS, Lee HM, Shin J, Kim DH, Lee KW, Eftekhari P, Quartier A, Park HS, Reddy ST. Vutiglabridin Modulates Paraoxonase 1 and Ameliorates Diet-Induced Obesity in Hyperlipidemic Mice. Biomolecules. 2023 Apr 18;13(4):687. doi: 10.3390/biom13040687. PMID: 37189434; PMCID: PMC10135725.

Tags: Cardiology/Epi, hyperlipidemia, Obesity, PON1, Publications, vutiglabridin

The noncanonical NFκB pathway: Regulatory mechanisms in health and disease

Rodriguez BN, Huang H, Chia JJ, Hoffmann A. The noncanonical NFκB pathway: Regulatory mechanisms in health and disease. WIREs Mech Dis. 2024 Nov-Dec;16(6):e1646. doi: 10.1002/wsbm.1646.[...]

Acute Coronary Syndrome in Women

Cader FA, Sareen N, Press MC. Acute Coronary Syndrome in Women. Interv Cardiol Clin. 2025 Jan;14(1):9-19. doi: 10.1016/j.iccl.2024.08.011. PMID: 39537292.

The Rebirth of Intraoperative Electrophysiological Mapping for Complex Congenital Heart Disease

Moore JP, Shivkumar K. The Rebirth of Intraoperative Electrophysiological Mapping for Complex Congenital Heart Disease. J Am Coll Cardiol. 2024 Nov 19;84(21):2113-2115. doi: 10.1016/j.jacc.2024.08.078. PMID:[...]